Correlation Between Terns Pharmaceuticals and Biovie

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Biovie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Biovie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Biovie Inc, you can compare the effects of market volatilities on Terns Pharmaceuticals and Biovie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Biovie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Biovie.

Diversification Opportunities for Terns Pharmaceuticals and Biovie

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Terns and Biovie is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Biovie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biovie Inc and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Biovie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biovie Inc has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Biovie go up and down completely randomly.

Pair Corralation between Terns Pharmaceuticals and Biovie

Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 0.5 times more return on investment than Biovie. However, Terns Pharmaceuticals is 2.0 times less risky than Biovie. It trades about -0.32 of its potential returns per unit of risk. Biovie Inc is currently generating about -0.16 per unit of risk. If you would invest  446.00  in Terns Pharmaceuticals on December 2, 2024 and sell it today you would lose (77.00) from holding Terns Pharmaceuticals or give up 17.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Terns Pharmaceuticals  vs.  Biovie Inc

 Performance 
       Timeline  
Terns Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Biovie Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Biovie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Terns Pharmaceuticals and Biovie Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Terns Pharmaceuticals and Biovie

The main advantage of trading using opposite Terns Pharmaceuticals and Biovie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Biovie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biovie will offset losses from the drop in Biovie's long position.
The idea behind Terns Pharmaceuticals and Biovie Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk